Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind trial of dapagliflozin in type 2 diabetes mellitus
2008-001921-33Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dapagliflozin in type 2 diabetes mellitus (T2DM) (5 arms), sponsored by Bristol Myers Squibb. Primary endpoint: Change in HbA1c from baseline to Week 24. Started Jul 2008; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-001921-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001921-33.